Cholesterol News

Today in The Roanoke Times you will find ads from at least two pharmaceutical companies with money-saving offers on two name-brand medicines, the cholesterol-reducing drug Lipitor and the quit-smoking drug Chantix.

The second phase of a monumental pharmaceutical study was released a few days ago, and women everywhere must pay attention.

The American Heart Association says high cholesterol affects more than 30 million Americans, and two of the most popular prescription drugs used widely to treat it are in question again.

Even adults at moderate risk for developing heart disease can benefit from these medicines.

It isn't often that a study involving a couple of hundred people shakes up medical science.

For many years, Merck has been a leader in developing drugs designed to fight so-called "bad" cholesterol, thus reducing the risk of clogged arteries and heart disease.

Dear Dr. Gott: Like several of your readers, I, too, suffered from painful muscle aches after taking various statin drugs for cholesterol control.

Abbott Laboratories said Teva Pharmaceutical Industries Ltd. won't sell the 145-milligram version of Abbott's TriCor cholesterol-lowering drug until at least 2011 under a patent-infringement lawsuit settlement.

In the week ending Friday, Nov. 20 - after the American Heart Association and New England Journal of Medicine released results of the Arbiter 6-HALTS study on Saturday, Nov.

Dispute highlights challenges facing drug groups in the Philippines, writes Roel Landingin.

A small study is causing a big splash in the multi-billion dollar world of cholesterol treatments.

By a margin of 0.014 mm in carotid intima-media thickness , extended-release niacin demonstrated superiority over ezetimibe as an add-on for high risk patients on long term statin therapy.

Q. Do you know about the "wet pajama" treatment for childhood eczema? Wet a pair of cotton pajamas and wring them out.

It seems just about everyone these days is aware of cholesterol because of the relentless daily barrage of advertisements from the pharmaceutical companies pushing these cholesterol-lowering statin drugs like Lipitor, Crestor, and the like.

Merck Expresses Confidence In The Efficacy And Safety Profiles Of ZETIA And VYTORIN As Effective Medicines For Managing Elevated Cholesterol November 18, 2009 At the American Heart Association meeting recently, Merck & Co., Inc.

The drug's maker, Merck & Co., didn't wait for the bad news to break. In anticipation of the findings, executives including Peter Kim, president of Merck Research Laboratories, and Richard Pasternak, Merck's head of global scientific affairs, sought to discredit the study by calling it 'flawed' and misleading in press interviews and through a ...

A new study brings a new blow to Zetia . In a recent study published by the New England Journal of Medicine, it appears that taking the extended release form of a common supplement, niacin, works better in reducing atherosclerotic plaque thickness than Zetia, a newer cholesterol drug that is used to specifically lower LDL cholesterol.

In the study presented today at the American Heart Association Scientific Sessions in Orlando, Florida today, The Effect of Extended-release Niacin or Ezetimibe Added to Chronic Statin Therapy On Carotid Intima Media Thickness , study found that: Adding the cholesterol drug niacin to a statin improved HDL cholesterol levels and significantly ...

A month's supply of some of the latest diabetes medicines can cost more than $100 or even $200 if a patient is forced to pay out of pocket, says diabetes doctor Mark Schutta.

Niacin: Safe and effective treatment for cholesterol? Lynn MacPherson Niacin: Safe and effective treatment for cholesterol? Many Americans battle high cholesterol levels and are looking for treatments that are safe and effective with few side effects.